Daniel N. Sundaram-Meenakshi
Edmonton, AB T6G1H9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia.
Journal: ACS pharmacology & translational science
Published: June 03, 2024
Tuning the Potency of Farnesol-Modified Polyethylenimine with Polyanionic Trans-Booster to Enhance DNA Delivery.
Journal: ACS biomaterials science & engineering
Published: February 09, 2024
Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems.
Journal: Molecular pharmaceutics
Published: January 31, 2024
Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 20, 2023
An optimized polymeric delivery system for piggyBac transposition.
Journal: Biotechnology and bioengineering
Published: September 30, 2023
Nanoparticles and cytokine response.
Journal: Frontiers in bioengineering and biotechnology
Published: June 21, 2023
Transfection Efficacy and Cellular Uptake of Lipid-Modified Polyethyleneimine Derivatives for Anionic Nanoparticles as Gene Delivery Vectors.
Journal: ACS applied bio materials
Published: February 28, 2023
In Vitro Cytotoxicity and Cytokine Production by Lipid-Substituted Low Molecular Weight Branched PEIs Used for Gene Delivery.
Journal: Acta biomaterialia
Published: February 04, 2022
Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
Journal: The journal of gene medicine
Published: November 01, 2021
Polymeric siRNA delivery targeting integrin-β1 could reduce interactions of leukemic cells with bone marrow microenvironment.
Journal: Biomaterials and biosystems
Published: May 28, 2021
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options.
Journal: Drug discovery today
Published: December 23, 2018
Last Updated: 09/26/2026